Pharmaceutical composition for preventing and treating cerebral infarction
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JIAMUSI UNIVERSITY
- Publication Date
- 2020-01-10
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to the field of medicine, in particular, the present invention relates to a pharmaceutical composition comprising Phellodendriline, Paeoniflorin and optionally EGCG, a preparation method, and an application thereof for preventing and treating cerebral infarction. Background technique
[0002] Cerebral infarction, also known as ischemic stroke, refers to the localized ischemic necrosis or softening of brain tissue caused by cerebral blood supply disturbance, ischemia, and hypoxia. The common clinical types of cerebral infarction include cerebral thrombosis, lacunar infarction, and cerebral embolism. Cerebral infarction accounts for 80% of all strokes. . Cerebral infarction not only poses a great threat to human health and life, but also brings great pain and heavy burden to patients, families and society.
[0003] After the onset of cerebral infarction, under the action of various pathophysiological mechanisms, neuronal c...